Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.

MLA

Gurnari, Carmelo, et al. “Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT.” Blood Advances, vol. 8, no. 6, Mar. 2024, pp. 1444–48. EBSCOhost, https://doi.org/10.1182/bloodadvances.2023012478.

APA

Gurnari, C., Koster, L., Baaij, L., Heiblig, M., Yakoub-Agha, I., Collin, M., Passweg, J., Bulabois, C. E., Khan, A., Loschi, M., Carnevale-Schianca, F., Crisà, E., Caravelli, D., Kuball, J., Saraceni, F., Olivieri, A., Rambaldi, A., Kulasekararaj, A. G., Hayden, P. J., … McLornan, D. P. (2024). Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT. Blood Advances, 8(6), 1444–1448. https://doi.org/10.1182/bloodadvances.2023012478

Chicago

Gurnari, Carmelo, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, et al. 2024. “Allogeneic Hematopoietic Cell Transplantation for VEXAS Syndrome: Results of a Multicenter Study of the EBMT.” Blood Advances 8 (6): 1444–48. doi:10.1182/bloodadvances.2023012478.